OBJECTIVES To determine whether associations might be found, in patients with chronic airflow obstruction, between symptoms, peak flow rate (PEF), and particle mass and numbers, and to assess which measure was most closely associated with changes in health. Epidemiological studies have shown associations between particulate air pollution and cardiovascular and respiratory disease, and it has been proposed that these may be mediated by particles of nm size (ultrafine).
METHODS Relations were investigated between symptom scores, PEF, and bronchodilator use in 44 patients aged ⩾50 years with chronic obstructive pulmonary disease, and daily measurements of both mass of ambient particles of aerodynamic diameter less than 10 μm (PM10) and numbers of ultrafine particles (<100 nm), allowing for meteorological variables. Symptom scores, bronchodilator use, and PEF were recorded daily for 3 months. Counts of ultrafine particles were made by the TSI model 3934 scanning mobility particle sizer (SMPS) and PM10 measurements by the tapered element oscillating microbalance (TEOM).
RESULTS Ultrafine particle counts indoors and outdoors were significantly correlated, those indoors being about half of those outdoors. No associations were found between actual PEF and PM10 or ultrafine particles. However, there was a 19% increase in the rate of 10% decrements in daytime PEF with increases in PM10 from 10 to 20 μg/m3 which was of borderline significance (p=0.05). A change in PM10 from 10 to 20 μg/m3 was significantly associated with a 14% increase in the rate of high scores of shortness of breath (p=0.003). A similar change in PM10 as a moving average of the same day and 2 previous days was associated with a 31% increase in the rate of high scores for cough (p=0.02). Cough symptoms were also associated with lower temperatures (p=0.02). Higher use of medicines was also associated with higher PM10, but the increases were very small in clinical terms.
CONCLUSIONS Evidence was not found to support the hypothesis that the component of particulate pollution responsible for effects on respiratory symptoms or function resides in the fraction below 100 nm diameter. The consistent associations between symptoms and PM10 suggest that a contribution of the coarser fraction should not be dismissed. Further studies will be needed before the conclusions of this specific project may be generalised.
- air pollution
- ultrafine particles
- chronic obstructive lung disease
Statistics from Altmetric.com
There is evidence that particulate air pollution, even at the relatively low concentrations prevalent currently in United Kingdom cities, may be responsible for adverse effects on health.1The main associations seem to be with respiratory and cardiac effects, particularly in older people, and it seems likely that the effect of particles is to cause exacerbation of already existing disease in vulnerable people. As the effects are acute, occur at relatively low concentrations, and are associated with particles of apparently innocuous composition (largely carbon and ammonium sulphate and nitrate), it has been necessary to consider a novel pathogenic mechanism. One that has been proposed is that the pathogenicity of the particles is based not on the mass inhaled but rather on their numbers, and thus the surface area available to react with epithelial and inflammatory cells in the lung.2
This hypothesis was based partly on the finding that rats exposed to very small particles have markedly more pulmonary inflammation than do rats exposed to the same mass of material of larger size,3 4 and partly on knowledge that the particles derived from combustion characteristically found in urban air are predominantly in the ultrafine (<100 nm) size range. Subsequent work has suggested that such particles may exert adverse biological effects by release of toxic free radicals from their surfaces.5
Control of the problem of adverse health effects of particulate pollution depends on reduction of the exposures of populations to the toxic components of the pollutant. This is currently effected by control of the fraction of particles less than 10 μm in aerodynamic diameter (PM10). However, this metric may be dominated by larger, wind blown particles in the size range 1–10 μm, rather than by the much more numerous ultrafine particles (UFP). In theory therefore, if the ultrafine hypothesis is correct, PM10 may in some circumstances seriously misrepresent the toxicity of the pollutant. It is thus desirable to attempt to determine a metric that better represents the toxic component, so that ultimately this may be used as the basis for a standard for monitoring pollution control. We here report a study in which we have investigated associations between health effects in a panel of vulnerable people and both PM10 and measurement of the number of particles below 100 nm diameter.
Subjects and methods
A Skyeminimet SDL2990 weather station installed on the roof of the department's pollution laboratory located in central Aberdeen provided continuous data on temperature, relative humidity, wind speed, and wind direction. This was stored on a spreadsheet and later converted to values for daily mean, minimum, and maximum measurements. Wind direction was summarised as the number of days with wind from directions falling in each of eight sectors.
Air pollution data
PM10 measurements were obtained from a Rupprecht and Patashnick tapered element oscillating microbalance (TEOM) ambient particulate monitor of Aberdeen City Council. This was also located at a background site in the city centre, about 2 miles from our laboratory. Data were compressed to daily 24 hour mean, minimum, and maximum values. A TSI model 3934 scanning mobility particle sizer (SMPS) was used for sizing and counting aerosols of less than a μm. The SMPS system comprises a TSI model 3071A electrostatic classifier and a model 3022A condensation particle counter. Hourly samples were made in two scans, each sample lasting for 5 minutes at an automatically regulated flow rate of 5 l/min. Data were exported onto spreadsheets.
As the patients spent much time indoors, in a separate exercise a comparison of particle counts was made inside and outside the laboratory with windows closed. Only background counts were considered as indoor counts vary with combustion of domestic fuels. Seventy nine concurrent measurements of indoor and outdoor counts were run for 2 months of this 3 month study.
Approval for the study was obtained from the joint ethics committee of the Grampian Health Board and the University of Aberdeen. Patients were recruited from chest clinics at the Aberdeen Royal Hospitals; 44 gave written consent to participate in the study. They had airflow obstruction associated with either asthma or chronic obstructive pulmonary disease and answered positively when asked if the weather affected their chest. All were 50 years or above in age and resident within 5 miles of the air monitoring sites. They completed a questionnaire inquiring about their house, general indoor and outdoor activities, and exposure to dusts, fumes, and cigarette smoke. They were then asked to keep a daily diary of chest symptoms, use of inhalers, and twice daily peak expiratory flow (PEF) for 3 months.
The Ferraris Medical Poketpeak peak flow meter was used, recording between 90 and 710 l/min. Each subject was instructed in its use and asked to record the best of three blows twice a day. Scores for cough and shortness of breath were graded once daily on a 6 point scale 0–5, 0 for no symptoms at all and 5 for the worst possible symptoms. Total number of puffs on an inhaler was recorded. Night time scores were recorded as were those the next morning at about 0800 before the use of any drugs. Daytime symptoms were recorded at about 2000.
ANALYSIS OF DATA
All the measurements made were entered on spreadsheets. Symptom scores for cough and shortness of breath were further categorised as high if scored as 3 or higher and low if scored as 2 or lower. Presence or absence of any symptoms was not chosen as an outcome because most subjects reported some symptoms each day. We took two approaches when looking at the influence of particles on PEF. Firstly the actual PEF value for each person was examined. Secondly we analysed the presence or absence of a 10% decrement in PEF on each day relative to that person's median PEF, in view of the suggestion of Hoeket al 6 that this may be a more clinically important indicator than PEF itself. The percentage decrement was calculated as 100 (daily PEF−median PEF)/median PEF. These outcomes, whether continuous or binary, were examined relative to the mean meteorological and pollution measurements on the same day and as a 3 day moving average.
When examining the actual values of PEF for each person the Cochrane-Orcutt regression procedure with the prais function within Stata was selected,7 and adjustments were made for first order autocorrelation.8 Durbin Watson tests were used to check whether these adjustments for the high correlation between sequential measurements were sufficient. This regression took account of the fact that there were many observations on the same subject and resulted in a regression equation for today's health measurement including potentially influential environmental factors, adjustment for the previous day's health measurement, and a subject specific component. Generalised estimating equations were used to examine the binary outcomes for the presence of a 10% decrement in PEF and the presence of high levels of symptoms of cough or shortness of breath.9 The xtgee function within Stata was used as this was designed for panel data and can be set to adjust for first order serial association. Significance was taken to be at the conventional 5% level. No adjustment was made for multiple testing, and the increased probability of spurious associations is acknowledged in the discussion.
Of the 44 who agreed to take part, 27 had complete data for PEF, symptoms, and medicine use. Eight others had more than 80% of required data, and six had some usable data, leaving three that provided none of value. The age range of patients was between 50 and 79 years and was normally distributed (mean (SD) 66.45 (8.23)). There were 25 men (57%) and 19 women (43%), 38 (86%) being non-smokers, nine (20%) of them lifetime non-smokers.
RELATION BETWEEN OUTDOOR AND INDOOR ULTRAFINE PARTICLE COUNTS
There was a highly significant relation between outdoor and indoor ultrafine particle counts (p<0.0001, fig 1), the indoor counts being over half those of the outdoor counts. The linear regression equation was:
ASSOCIATIONS BETWEEN PARTICLE MEASURES AND HEALTH INDICES
Because of some loss of data owing to equipment malfunction over Christmas, there were 78 valid daily counts of ultrafine particles and 85 of PM10 over the 90 day measurement period. The distribution of pollution measurements was highly positively skewed (table 1), so natural logs of these were taken before they were considered in regression models.
Interrelations of particle measures
The two measures of particulate pollution were significantly correlated: PM10 to ultrafine particle numbers (r=0.49).
On every day of the 90 day period records were available for temperature (oC), relative humidity (RH%), wind speed (m/s), and wind direction in degrees. Wind speed was positively skewed, but temperature and humidity were close to normal in distribution. Average results for wind speed, temperature, humidity, and the percentage of days with each wind direction are shown in table 2. Wind was most often from the south south west sector. Of the meteorological variables, only wind speed varied with wind direction and was greatest on the few days that the wind was from the north east.
The mean PEF measurements over all subjects were normally distributed with values of 264 l/min in the morning and 267 l/min at night (table 3). The mean proportion (of those with available data on that day) who had high levels of symptoms was 50% (range 32% to 65%) for shortness of breath and 31% (range 15% to 47%) for cough. There were positive correlations between mean humidity and both pollution measures of about 0.4. PM10 was positively correlated with mean and maximum temperature (r=0.26).
The simple correlations between the original scores of cough and shortness of breath and use of medicine were all positive and greater than 0.5. There were the expected negative associations between both daytime and night time PEF and symptom scores and use of medication (p<0.001). No significant correlations were found between PEF and any of the particulate or meteorological measurements. Wind direction was not associated with any of the health outcomes. Thirty five subjects provided at least 80% of the requested data and so were included in the analysis of PEF. There were great differences between people in both median PEF and the range over the 90 days of follow up.
The results displayed in tables 4-6 are odds ratios for changes of 1 unit of measurement—for example, 1oC in temperature, 1 m/s in wind speed, 1% in relative humidity, and a change of 1 in the log of PM10. This is equivalent to a change from 6 to 16 μg/m3 or 10 to 27 μg/m3. Over the 90 days the average temperature was 4.8oC, humidity was 81%, and the median wind speed was 1.26 m/s. When interpreting the odds ratios for changes in PM10 we have kept the values of the potential confounders fixed at these average daily values.
In regression models for lung function, allowing for first order autocorrelation, none of the meteorological variables was associated with daytime or night time PEF. No significant associations were found between daytime or night time PEF and the two measures of pollution after adjustment for confounders.
Selected results for PEF and symptoms are shown in figure 2. No association was found between ultrafine particles and decrements of 10% in daytime or night time PEF. However, associations were found between the decrements of 10% in daytime PEF and increasing values of log PM10 on the same day which were of borderline significance after adjusting for mean temperature, wind speed, humidity, and serial association. The odds ratio for a change from 10 to 20 μg/m3 was 1.19 (95% confidence interval (95% CI) 1.00 to 1.42). On an average day with a PM10 of 10 μg/m3 the rate of 10% decrement in daytime PEF would be 15% of the people. At PM10 of 20 μg/m3 it would be 18% and at 30 μg/m3 it would be 19%.
We used the same generalised estimation equation approach to look for the presence of high levels of symptoms (⩾3) in 35 subjects. No significant associations between symptoms and ultrafine particles were found. High levels of symptoms of cough were significantly associated with lower mean temperatures (p=0.02) and higher log of PM10 over the previous 3 days (p=0.02) after adjusting for autocorrelation, mean wind speed, and humidity (table 5). The odds ratio shown is for a 1 unit change in log of PM10 as a 3 day average. The odds ratio for a change of 0.7 units, equivalent to a change of 10 to 20 μg/m3, was 1.31 (1.05 to 1.63). On an average day with a PM10 as a 3 day average of 10 μg/m3 the rate of high levels of symptoms of cough would be 28%. If this measure of PM10 was 20 μg/m3it would be 34%, and at 30 μg/m3 it would be 38%.
There was a significantly positive association between high levels of symptoms of shortness of breath and log same day PM10(p=0.003). This association remained significant after adjusting for wind speed, humidity, and temperature (table 6). The odds ratio shown is for a 1 unit change in log of PM10 over the previous 3 days. The odds ratio for a change of 0.7 units, equivalent to a change 10 to 20 μg/m3, was 1.14 (1.05 to 1.25). On an average day with a PM10 over the 3 previous days of 10 μg/m3 the rate of high levels of symptoms of shortness of breath would be 47%. If this measure of PM10 was 20 μg/m3 it would be 50%, and at 30 μg/m3 it would be 52%.
Medicine use was treated as a continuous measure. The values in the model shown in table 7 are estimates of the mean change in use of medicine for 1 unit change in the relevant factor. There was an association between high use of medicine and higher same day PM10 (p=0.04) which was significant after adjusting for autocorrelation, mean temperature, wind speed, and humidity. The size of this effect was very small in clinical terms. An increase of 1 unit in log PM10 was associated with a 0.12 increase in the dose of medicine used. On an average day, use increased from 4.30 doses to 4.43 doses as PM10 increased from 10 to 30 μg/m3. The estimates for the model including log PM10, mean temperature, wind speed, and humidity showed a significant association between increasing log PM10 and the higher use of medication.
Control of particulate air pollution, unlike that of other pollutants, is based on a physical rather than chemical measurement. The particles as measured may therefore be of a wide range of different compositions, and contain both chemicals and biological matter. Nevertheless, epidemiological studies have shown similar associations between adverse health effects and particulate pollution, wherever it is measured, whatever the main sources, and whether it has been measured as PM10 or black smoke, which represents a smaller size range. This suggests that there may be a common factor in particles responsible for adverse effects. Theoretical arguments and experimental studies suggest that much of the toxic component may lie in the fraction below about 1 μm, and most probably in particles of <100 nm diameter. At present there are relatively few data allowing an epidemiological test of this hypothesis, and time series studies comparing PM10 with PM2.5 have so far been unable to separate their effects as the two measures are highly correlated. The work reported here suggests that, whatever the effects of ultrafine particles, the contribution of particle mass (and by implication, the larger particles) towards respiratory ill health cannot be dismissed.
Few studies have previously looked at counts of particles relative to health. In a cohort of asthmatic children, whose main source of particulate air pollution was motor vehicle exhaust from freeways, the number of ultrafine particles was found to be no more strongly associated with variations in PEF than was PM10 or black smoke.10 By contrast, the same group of authors found a stronger effect of particle numbers in asthmatic children in two other studies,11 12 and a German study has shown the ultrafine fraction to be more strongly associated with decrease in lung function in adult asthmatic patients than was PM10.13We found a very strong correlation between indoor and outdoor ultrafine particles with those indoors being half of these outdoors, so any health influences will be hard for susceptible people to avoid.
Our study shows some of the problems in such research, particularly relating to the difficulty of differentiating between the effects of different but intercorrelated particle measures and confounding weather variables. There is, however, some consistency with these other studies.14 15 The associations we did find were in the anticipated direction, both symptoms and peak flow deteriorating as pollution increased. No association was statistically strong, reflecting small numbers and relatively little individual variation in the indices we measured. It should also be noted that the levels of pollution were very low in historic terms—PM10 did not rise higher than 40 μg/m3—in other words no episode of pollution occurred over the period of the study, and it is perhaps remarkable that effects were found at such concentrations. We think that the strongest results of our study are those from the regression models, as multiple simple correlations will be affected by chance positive findings and the confounding effects of weather. We can therefore summarise our positive findings as having shown two main associations, one between high scores of shortness of breath and same day PM10, and the other between high scores of cough and 3 day PM10. The association with PM10 was little influenced by weather confounders. The other association between 10% decrements in daytime PEF and same day PM10 did not quite reach conventional levels of significance but was consistent with the other findings.
The power within this study was limited by few patients who returned all the required data and by the small range of particulate measurements. Time series studies only slightly bigger than this have been reported before, but these had greater power because of the greater range of PM10 linked to nearby industrial processes. There is also the possibility in our study of spurious associations because there were four measures of pollution and seven health outcomes. We might expect one or two significant associations even if there were no real effects. However, this is offset by the consistency in the size and direction of the same day and 3 day average PM10 measures for each of the outcomes, although not all were significant, and the consistency in the direction of the associations across four of the health outcomes.
It is perhaps going beyond what the data allow to speculate as to whether these results are biologically plausible. However, it is conceivable that larger particles, together with weather, might affect the airways primarily and that mass may be important in this respect. The original ultrafine hypothesis was proposed as an explanation of downstream effects of low concentrations of particulate pollution on the cardiovascular system, and it remains possible that such effects are explicable by alveolar inflammation affecting blood rheology. However, in our direct test of particulate pollution on the blood , we also showed effects of PM10.16 Whatever the explanation, it seems clear that it would be premature to replace the measurement of PM10 with that of a finer fraction on what are to date largely theoretical grounds. Longer time series studies and larger studies such as this of panels of susceptible subjects will be necessary. Also, it is highly desirable to develop means of estimating exposures of people to the finer fractions of particulate pollution to increase the ability of these studies to pick up what seem to be weak effects in the pollution conditions present currently in the United Kingdom.17 18
This study was supported by a grant from the United Kingdom Department of Health and an equipment grant from Aberdeen University. We are grateful to Ferraris Medical for their gift of peak flow meters. We are also particularly grateful for the helpful comments of the anonymous referees on an earlier draft of this paper.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.